CHU Grenoble Alpes
La Tronche, ISERE, 38700, France
NCT Number: NCT06657053
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied.
The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
La Tronche, ISERE, 38700, France
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied : oral anticoagulants, sex, INR, anti-platelets drugs, diabetes, obesity, arterial hypertension, heart failure, hemoglobin at the admission, history of chronic rhinosinusitis, appointment with an ENT during the acute bleeding, sleep apnea, age, anatomic abnormality, recent surgery within 2 months, previous admission within 30 days in the emergency department, nasal trauma.
The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.
This study aim to provide a pronostic score of recurrence that can happen after the 3 fisrt weeks after the event. When a recurrence happens before 3 weeks, this was considered to be a non control of the bleeding episode.
This score will be then tested on our cohort to evaluate specificity and sensibility.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Measuring the delay between the first epistaxis and a recurrence.
Contact information is provided by the study sponsor or research team.
University Hospital, Grenoble
Other
Facteurs De Risques De Récidive D'épistaxis Chez L'adulte
Acronym: FREA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07531472
Epistaxis, Hemorrhage
View Trial DetailsNCT07511192
Epistaxis, Hemorrhage
View Trial DetailsNCT06836102
Epistaxis, Hemorrhage
View Trial DetailsNCT06259292
Arteriovenous Malformations, Brain Diseases
Birmingham, Alabama, United States
View Trial Details